Based on the aggregated intelligence of 145,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, insurance company Dentsply International (NASDAQ:XRAY) has earned a respected four-star ranking.

With that in mind, let's take a closer look at Dentsply's business and see what CAPS investors are saying about the stock right now.

Dentsply International facts

Headquarters (Founded)

York, Penn. (1983)

Market Cap

$5.2 billion


Health care equipment and supplies

Trailing-12-Month Revenue

$2.1 billion


CEO Bret W. Wise
CFO William R. Jellison

Return On Equity, 3-Year Average



Cantel Medical (NYSE:CMN)
Procter & Gamble (NYSE:PG)

Component of


CAPS Members Bullish on Dentsply Also Bullish on

Johnson & Johnson (NYSE:JNJ)

CAPS Members Bearish on Dentsply Also Bearish on


Sources: Capital IQ (a division of Standard & Poor's) and Motley Fool CAPS.

On CAPS, 95.3% of the 213 members who have rated Dentsply believe the stock will outperform the S&P 500 going forward. These bulls include nelsonic72 and LondonMatt.

A few months ago, nelsonic72 said he liked Dentsply: "Beaten down stock which will rebound with everything else. Supplier which won't be affected by healthcare reform."

In a pitch from earlier this year, londonmatt liked Dentsply's depth:

Market leader with significant levels of repeat business. Growing sales and an internationally diversified presence in 120 countries. Dental consumables business means repeat customers, in a market where the professionals (dentists) demonstrate brand loyalty -- not at the whim of the consumer.

What do you think about Dentsply, or any other stock for that matter? Make your voice heard on Motley Fool CAPS today. The CAPS community is waiting to hear your opinions. CAPS is 100% free, so get started!

Dan Dzombak owns no position in any of the companies mentioned. FedEx is a Motley Fool Stock Advisor pick. 3M is an Inside Value recommendation. Johnson & Johnson and Procter & Gamble are Income Investor picks and the Fool owns shares of P&G. The Fool has investors writing for investors.